Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20082117 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: MDX-010 (CTLA-4)

Indicates status has not been verified in more than two years